HUMAN TRANSCRIPTION FACTOR IMMUNOGENS: GENERATION OF A COMPLETE SET
HUMAN TRANSCRIPTION FACTOR IMMUNOGENS: GENERATION OF A COMPLETE SET
批准号:
8305707
负责人:
Stephen Anderson
金额:
$84.64万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-09-23 至 2015-08-31
关键词:
AddressAffinityAffinity ChromatographyAgreementAntibodiesAntigensArchivesArizonaAtlasesAttentionBaculovirusesBindingBinding ProteinsBiologicalCellsCharacteristicsChromatinCollectionComplexCytolysisDNADatabasesDepositionDiseaseDocumentationElectronicsEmbryoEnsureEpitopesEscherichia coliExhibitsFutureGenerationsGenesGeneticGerm CellsGoalsHumanHuman BiologyHuman Genome ProjectInformaticsInsectaInstructionLaboratoriesMalignant NeoplasmsMembraneMetalsMiningMonoclonal AntibodiesOccupationsPlasmidsPrincipal InvestigatorProceduresProcessProductionProteinsProteomeProtocols documentationReagentRecombinant ProteinsRecombinantsRecordsResidual stateResourcesRunningSamplingScheduleScientistScreening procedureSequence AnalysisShippingShipsSoftware ToolsStructureSystemTechnologyTestingUniversitiesWheatWorkYeastsbasechromatin immunoprecipitationcost effectivedesigndesign and constructionexperienceexpression vectorkidney cellmeetingsmilligrampolypeptideprotein expressionrepositoryscale upsuccessthree dimensional structuretranscription factorvectorwasting
中文摘要
提出的项目的目标是组装一个优化的免疫原集合基于
英文摘要
The goal of the proposed project is to assemble a collection of optimized immunogens based on the
complete set of human transcription factors. These immunogens will be used by others to create renewable
affinity reagents such as monoclonal antibodies. An initial, high priority appiication envisioned for such
reagents is chromatin immunoprecipitation studies, and our aim is to design our immunogens so as to
optimize them for this purpose. We will do this primarily using two strategies: (a) we will express
transcription factor domains that flank the DNA recognition domain but do not overlap it in order to minimize
inducing antibodies that might interfere with chromatin binding; and (b) wherever possible we will focus on
transcription factor flanking domains that fold into complex three dimensional structures (native folds) and
thus present highly specific 3D epitopes. We already have a protein production pipeline up and running that
is producing > 1000 purified protein samples (including hundreds of human proteins) per year at the multi-
milligram scale, so we are highly experienced in the relevant technologies, and meeting the goals of this
FOA will require adding only a modest amount of extra capacity. We also have specialized software tools for
the sophisticated analysis of human transcription factor sequences and the design of appropriate expression
constructs. Our experience has shown that paying attention to the proper curation of genes and construct
design at the beginning pays dividends downstream in terms of timely and cost-effective protein production
because it minimizes wasting expensive wet lab resources on sub-par targets. Finally, we have a range of
adaptable expression technologies that can be tailored to other classes of human protein targets (including
secreted and membrane-bound proteins) in the future, so our approach is highly amenable to expressing
additional sectors of the human proteome beyond transcription factors.
RELEVANCE (See instmctions):
The human genome project gave us a complete blueprint for the genetic instructions that control human
biology. This proposal concerns a special set of human proteins known as "transcription factors", which
are the master effector.proteins in the cell that have the job of interpreting these instructions and telling the
cell what to do under all sets of conditions. In diseases such as cancer these instructions can become
garbled, which is why it is important to understand how transcription factors work. This proposal concerns
the creation of a specific collection of human transcription factor-derived proteins that will allow scientists to
precisely interrogate which transcription factors address which sets of instructions under a variety of
conditions, thus establishing the outlines of the master control circuits in human cells.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
HUMAN TRANSCRIPTION FACTOR IMMUNOGENS: GENERATION OF A COMPLETE SET
-
批准号:8146979
-
项目类别:
-
资助金额:$98.64万
-
财政年份:2010
-
负责人:Stephen Anderson
-
依托单位:
HUMAN TRANSCRIPTION FACTOR IMMUNOGENS: GENERATION OF A COMPLETE SET
-
批准号:8904907
-
项目类别:
-
资助金额:$103.15万
-
财政年份:2010
-
负责人:Stephen Anderson
-
依托单位:
HUMAN TRANSCRIPTION FACTOR IMMUNOGENS: GENERATION OF A COMPLETE SET
-
批准号:8755145
-
项目类别:
-
资助金额:$85.0万
-
财政年份:2010
-
负责人:Stephen Anderson
-
依托单位:
HUMAN TRANSCRIPTION FACTOR IMMUNOGENS: GENERATION OF A COMPLETE SET
-
批准号:8067553
-
项目类别:
-
资助金额:$97.99万
-
财政年份:2010
-
负责人:Stephen Anderson
-
依托单位:
HUMAN TRANSCRIPTION FACTOR IMMUNOGENS: GENERATION OF A COMPLETE SET
-
批准号:8532451
-
项目类别:
-
资助金额:$49.99万
-
财政年份:2010
-
负责人:Stephen Anderson
-
依托单位:
海外基金